A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
Source:http://linkedlifedata.com/resource/pubmed/id/9404698
Cancer
1997
Dec
15
80
12
2222-9
